Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
about
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventionsProbiotics and blood pressure: current insightsListening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisThe contributory role of gut microbiota in cardiovascular diseaseThe gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseasesEffective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysisTrimethylamine N-Oxide: The Good, the Bad and the UnknownIntestinal Microbiota Metabolism and AtherosclerosisThe Microbiome and Sustainable Healthcare.Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisImpaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patientsThe dormant blood microbiome in chronic, inflammatory diseases.Streptomyces exploration is triggered by fungal interactions and volatile signals.γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAOMicrobiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.Nutri(meta)genetics and cardiovascular disease: novel concepts in the interaction of diet and genomic variationUnraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.Carnitine in bacterial physiology and metabolism.Anaerobic choline metabolism in microcompartments promotes growth and swarming of Proteus mirabilisTrimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuniMetagenomic data-mining reveals contrasting microbial populations responsible for trimethylamine formation in human gut and marine ecosystems.Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome.Uncovering the trimethylamine-producing bacteria of the human gut microbiota.The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Gut Microbiota and Atherosclerosis.The gut microbiome in atherosclerotic cardiovascular disease.Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes MellitusIncreased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.Trimethylamine and trimethylamine N-oxide are supplementary energy sources for a marine heterotrophic bacterium: implications for marine carbon and nitrogen cycling.Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.CntA oxygenase substrate profile comparison and oxygen dependency of TMA production in Providencia rettgeri.The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction.The germ-organ theory of non-communicable diseases.Microbial modulation of cardiovascular disease.Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
P2860
Q26751203-B0700BA0-5D13-479E-8A8E-142909BC6225Q26767248-C5E9BE4B-A345-4C1C-A39D-C4D88431B8F4Q26823198-653D7236-6397-4DD5-9684-91C3BF143018Q26830828-D6AFDCD3-AE98-468B-8A75-599B3917150AQ27021692-E71A13D9-C5A3-4FEF-A1AB-56481BAC7B2DQ27027544-80844499-5102-4F99-B77E-4054E53A97C7Q28079182-D85465EE-E3D6-485E-B04C-2D26806E7874Q28081862-67FCB33C-0341-4727-B539-2A60693DD398Q28088606-1DC2C5D0-CC09-4120-B18D-C4EA6FCC215DQ29038812-A8BA7D62-FB1C-4330-ABED-7327D767AA27Q33684162-E9E8049A-EDCB-435E-B300-C66F340A62A0Q34474989-FF4D6EF1-9F65-41A3-A3A6-D18EB2B6DBA5Q34548457-E4423F12-B92A-47D5-9111-6DC7A0030744Q34630290-3997473C-8E58-4C22-82A2-0AADE9227F64Q35406034-E442DFAA-CEB8-401C-AC57-C3F852C0FDF3Q35457492-93F349AA-32F1-4B0B-A94E-B34F1A840D1EQ35662826-A9567AD4-7A2D-47FF-B39C-DCB5E8B7C257Q36228851-CE5AA74F-4B11-4497-983F-A7B8CA93ABD7Q36255176-5EF0EB8A-79CD-436F-A843-AF98223772BFQ37261624-678BA4EF-BF24-467C-AF52-AA4C27666FA4Q37357727-8338C306-2163-4844-8E44-AEF2DB733B5CQ37595816-490921C0-26F6-40CB-A413-A52EFCA20FFAQ38261033-31561565-2ACE-4237-814F-7086032D84A2Q38635841-DC5E196E-2FB3-4D7C-B418-39FDD46A0D52Q38741089-E95A737D-E12B-4C65-8A12-9FF36DA4F828Q38785297-32C03D0B-EED5-4752-A81D-43FE49603470Q38820418-715C44A8-D456-4854-AF22-23D3E1C3A043Q38918147-93BF6BD6-FD94-458A-88CB-BF8A64D94124Q40079055-7111355D-CCA3-4D65-90C0-C09832B65B86Q42265319-B13128FE-EE65-41A0-A34F-642E5BA6480BQ42373443-B58EBAF7-8CA2-48A7-97A3-05B91665EA2BQ42616677-87414E25-779F-425A-AE8C-1411DC417539Q43150913-AF50B260-55D4-4297-B9F4-5AF229F65592Q45849451-3018F846-6C1A-438A-8989-6E72FC695BA7Q47432996-EF1F102E-5A33-47C0-B542-30AD7C928370Q48047320-B398343C-8EDB-4DC1-9B02-C93B0B1C96E4Q49665445-253DCE55-B8BA-455B-9F86-BEF302AE48C0Q50144039-4FA5485B-DAA6-4767-9139-CE9846084CC0Q50144047-7D7F9755-6523-439A-8D59-A6835B28B5A7Q54302207-0F9F535A-5298-43C5-B04C-10282CE8B8A9
P2860
Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Carnitine metabolism to trimet ...... xygenase from human microbiota
@ast
Carnitine metabolism to trimet ...... xygenase from human microbiota
@en
type
label
Carnitine metabolism to trimet ...... xygenase from human microbiota
@ast
Carnitine metabolism to trimet ...... xygenase from human microbiota
@en
prefLabel
Carnitine metabolism to trimet ...... xygenase from human microbiota
@ast
Carnitine metabolism to trimet ...... xygenase from human microbiota
@en
P2093
P2860
P50
P356
P1476
Carnitine metabolism to trimet ...... xygenase from human microbiota
@en
P2093
Kumar Rajakumar
Marialuisa Crosatti
Timothy D H Bugg
P2860
P304
P356
10.1073/PNAS.1316569111
P407
P577
2014-03-03T00:00:00Z